Research Topics
Genomes and Genes | Diego AlbaniSummaryAffiliation: Istituto di Ricerche Farmacologiche Mario Negri Country: Italy Publications
| Collaborators
|
Detail Information
Publications
A polymorphic variant of the insulin-like growth factor 1 (IGF-1) receptor correlates with male longevity in the Italian population: a genetic study and evaluation of circulating IGF-1 from the "Treviso Longeva (TRELONG)" studyDiego Albani
Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Milan, Italy
BMC Geriatr 9:19. 2009..In humans, IGF-1 level has an age-related modulation with a lower concentration in the elderly, depending on hormonal and genetic factors affecting the IGF-1 receptor gene (IGF-1R)...
The serotonin transporter promoter polymorphic region is not a risk factor for Alzheimer's disease related behavioral disturbancesDiego Albani
Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Milan, Italy
J Alzheimers Dis 18:125-30. 2009..We conclude that 5-HTTLPR and rs25531 are not major genetic modulators of BPSD development in AD...
The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptideDiego Albani
Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Via La Masa 19, Milan 20156, Italy
J Neurochem 110:1445-56. 2009....
Serotonin transporter gene polymorphic element 5-HTTLPR increases the risk of sporadic Parkinson's disease in ItalyDiego Albani
Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Milan, Italy
Eur Neurol 62:120-3. 2009..5], p = 0.002) was found. The rs25531 and the haplotype 5-HTTLPR/rs25531 did not associate with risk of PD. Our data indicate that the 5-HTTLPR polymorphic element within the SLC6A4 promoter may govern the genetic risk of PD in Italians...
Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidenceDiego Albani
Laboratory of Biology of Neurodegenerative Disorders, Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Milan, Italy
J Alzheimers Dis 19:11-26. 2010....
Interleukin-6 plasma level increases with age in an Italian elderly population ("The Treviso Longeva"-Trelong-study) with a sex-specific contribution of rs1800795 polymorphismDiego Albani
Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Via La Masa 19, 20156, Milan, Italy
Age (Dordr) 31:155-62. 2009..05, Tukey's test) was also noticed. We suggest a sex-specific pattern for genetic variability linked to inflammatory response and longevity, consistent with the age-related increase in IL-6...
Association study to evaluate the serotonin transporter and apolipoprotein E genes in frontotemporal lobar degeneration in ItalyDiego Albani
Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Via La Masa 19, 20156 Milan, Italy
J Hum Genet 53:1029-33. 2008..A significant correlation [P = 0.018, OR (95% CI): 2.1 (1.1-3.9)] between rs4795541 S-allele presence and FTLD susceptibility was found. In summary, the rs4795541 might be important for FTLD susceptibility in the Italian population...
Presenilin-1 mutation E318G and familial Alzheimer's disease in the Italian populationDiego Albani
Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Via Eritrea 62, 20157 Milan, Italy
Neurobiol Aging 28:1682-8. 2007..05, Mann-Whitney test) in the Abeta(1-42)/Abeta(1-40) ratio in PSEN-1 [E318G] carriers, suggesting a peculiar biochemical effect of this mutation...
The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) levelMarzia Pesaresi
Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Via Eritrea 62, 20157 Milan, Italy
Neurobiol Dis 25:609-13. 2007..Our data support a role for PLAU_1 as an independent genetic risk factor for AD in the Italian population for those subjects who do not have the APOE-epsilon4 allele...
Interleukin-1α, interleukin-1β and tumor necrosis factor-α genetic variants and risk of dementia in the very old: evidence from the "Monzino 80-plus" prospective studyDiego Albani
Laboratory of Biology of Neurodegenerative Disorders, Mario Negri Institute for Pharmacological Research, Milan, Italy
Age (Dordr) 34:519-26. 2012..26), which was an independent predictor of dementia onset (p = 0.0002). In short, in this Italian population of oldest olds, dementia was associated to the APOE-ε4 allele only...
Early-onset Alzheimer disease in an Italian family with presenilin-1 double mutation E318G and G394VSara Batelli
Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Via Eritrea 62, Milan, Italy
Alzheimer Dis Assoc Disord 22:184-7. 2008..We did not find any modification of the A beta(1-42)/A beta(1-40) ratio, suggesting that this double mutation might be involved in early-onset AD etiopathogenesis by affecting a PSEN-1 function other than gamma-secretase activity...
DJ-1 modulates alpha-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70Sara Batelli
Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Milan, Italy
PLoS ONE 3:e1884. 2008..DJ-1 (PARK7), another family-PD-linked gene causing an autosomal recessive form of the pathology, shows antioxidant and chaperone-like activities too...
Insulin-like growth factor 1 receptor polymorphism rs2229765 and circulating interleukin-6 level affect male longevity in a population-based prospective study (Treviso Longeva--TRELONG)Diego Albani
Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Via La Masa, Milan, Italy
Aging Male 14:257-64. 2011..These findings sustain the hypothesis that sex-specific longevity relies on detectable differences in genetic and biochemical parameters between males and females...
A novel study and meta-analysis of the genetic variation of the serotonin transporter promoter in the italian population do not support a large effect on Alzheimer's disease riskLetizia Polito
Department of Neuroscience, Mario Negri Institute for Pharmacological Research, 20156 Milan, Italy
Int J Alzheimers Dis 2011:312341. 2011..85 (associated P value = .08). Overall, our findings are not supportive of a large genetic effect of the explored polymorphisms on AD risk...
Neuroprotective properties of resveratrol in different neurodegenerative disordersDiego Albani
Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Milan, Italy
Biofactors 36:370-6. 2010..Here, we summarize the in vitro and in vivo experimental results highlighting the possible role of resveratrol as neuroprotective biofactor with a particular focus on AD...
Multiplex assessment of a panel of 16 serum molecules for the differential diagnosis of Alzheimer's diseaseGloria Biella
Department of Neuroscience, Istituto di Ricerche Famacologiche Mario Negri IRCCS Milan, Italy
Am J Neurodegener Dis 2:40-5. 2013..63 and 0.66 for EGF and TRAIL-R4, respectively). Finally, we tried to find a diagnostic classifier by a multivariate algorithm. We found indication of diagnostic evidence for AD only, while NAD samples did not show a diagnostic pattern...
A novel PSENEN mutation in a patient with complaints of memory loss and a family history of dementiaDiego Albani
Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Milan, Italy
Alzheimers Dement 3:235-8. 2007..Although our data do not definitively support a pathogenetic role for this mutation, it does not appear to be a common polymorphism. Further follow-up is warranted in this family...
Genotype-dependent activity of tryptophan hydroxylase-2 determines the response to citalopram in a mouse model of depressionLuigi Cervo
Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, 20157 Milan, Italy
J Neurosci 25:8165-72. 2005..Interstrain comparisons could probably be a useful strategy for understanding the mechanisms underlying the response to selective serotonin reuptake inhibitors...
Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's diseaseChiara Fenoglio
Department of Neurological Sciences, Dino Ferrari Center, University of Milan, IRCCS Fondazione Ospedale Maggiore Policlinico, Milan, Italy
J Alzheimers Dis 18:603-12. 2009..14, CC = 1.22 +/- 0.23; P = 0.013). These data argue against a direct role of GRN as a susceptibility factor for sporadic AD but support a role of GRN as a disease-modifying gene, possibly contributing to the failure of neuronal survival...
Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitorsFilippo Martinelli-Boneschi
San Raffaele Scientific Institute, Division of Neuroscience, Laboratory of Genetics of Complex Neurological Disorders, Institute of Experimental Neurology INSPE, Milan, Italy
Neurobiol Aging 34:1711.e7-13. 2013..Despite its limitations, this project paves the way for the application of personalized medicine in AD patients and for collaborative efforts in this field...
Replication study to confirm the role of CYP2D6 polymorphism rs1080985 on donepezil efficacy in Alzheimer's disease patientsDiego Albani
Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Milan, Italy
J Alzheimers Dis 30:745-9. 2012..74 [1.01-3.00], p = 0.04). Rs1080985 might be useful as predictor of poor response to short-term donepezil treatment...
Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70Diego Albani
Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
FASEB J 18:1713-5. 2004..The implications for alpha-syn-mediated neurotoxicity and for PD pathogenesis and progression are discussed...
Glial cells drive preconditioning-induced blood-brain barrier protectionRaffaella Gesuete
Laboratory of Inflammation and Nervous System Diseases, Mario Negri Institute, Via G La Masa 19, 20156 Milan, Italy
Stroke 42:1445-53. 2011..The cerebrovascular contribution to ischemic preconditioning (IPC) has been scarcely explored. Using in vivo and in vitro approaches, we investigated the involvement of the blood-brain barrier and the role of its cellular components...
